Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 16 ... findings, but also examine both donor and host factors, including psychosocial, virologic, genetic and immunologic that may contribute to this important health disparity." ...
2009 NOV 16 ... or histologically active disease. This indication is based on histologic, virologic, biochemical, and serologic responses in nucleoside-naive and lamivudine-resistant adult ...
2009 NOV 16 ... than 3 log mean maximum decrease in viral load and two patients (29%) achieved a rapid virologic response (RVR), or undetectable HCV RNA copies, at 4 weeks. The most common ...
2009 NOV 16 ... cannot predict which patients may benefit from longer therapy, in-treatment virologic responses appear likely to do so. The lead-in strategy allows for an assessment to ...
2009 NOV 16 ... evaluation algorithm through 144 weeks showed that 87 percent of patients achieved virologic suppression (HBV DNA levels below 400 copies/mL), and similar efficacy was observed ...
2009 NOV 16 ... of hepatitis C. Hepatology: 2004(39):1147-1171. 3Veldt et al, "Sustained virologic response and clinical outcomes in patients with chronic hepatitis C and advanced ...
2009 NOV 17 ... The researchers concluded: "Antigen-based rapid tests appear unsuitable for virologic diagnostics in the current pandemic." Drexler and colleagues published ...
2009 NOV 23 ... the investigational drugs and had plasma HIV RNA levels >1000 copies/mL, a history of virologic failure while receiving nonnucleoside reverse-transcriptase inhibitors (NNRTI), >= 3 ...
2009 NOV 23 ... compiles the results of up to 2 years of treatment for protocol-defined responders, virologic responders and nonresponders," wrote T.T. Chang and colleagues, National Cheng-Kung ...
2009 NOV 16 ... USP) followed by the addition of narlaprevir, 85-87 percent of patients achieved rapid virologic response (RVR), compared to 58-75 percent of patients in the no lead-in narlaprevir arms ...
2009 NOV 23 ... interferon-alpha (PEG-IFN-alpha) plus ribavirin (RBV), does not provide sustained virologic response (SVR) in all patients. We report a genome-wide association study (GWAS) to null ...
2009 NOV 9 ... The primary efficacy end point was the cumulative proportion of patients with virologic failure, defined as a confirmed plasma HIV-1 RNA level >= 400 copies/mL, over 24 ...
2009 NOV 23 ... from antiviral therapy for HCV. The authors compared antiviral completion and sustained virologic response (SVR) rates between hepatitis C ( HCV) patients with versus those without ...
2009 NOV 16 ... Republic of China, "In 2007, a surveillance system for influenza-like illness (ILI) and virologic data was established in Beijing, China. The system tracked ILI and laboratory-confirmed ...
2009 NOV 9 ... report. "We assessed the influence of gB genotypes on the clinical and virologic outcome of CMV disease. Solid-organ transplant recipients enrolled in a multicenter ...
2009 NOV 16 ... C) or 48 weeks (group D). All patients received ribavirin, 1000 or 1200 mg/d. Sustained virologic response (SVR), defined as undetectable (<50 IU/mL) HCV RNA levels 24 weeks after the ...
2009 NOV 9 ... + EFV n = 19; 3TC + ZDV + EFV, n = 31) were analyzed for resistance development after virologic failure. NNRTI-R, primarily the K103N mutation, was the most common form of resistance ...
2009 NOV 16 ... viral suppression, clear all HCV-infected hepatocytes and ultimately lead to a sustained virologic response (SVR)," said Dr. Gane. He concluded by saying, "as we explore this new ...
2009 NOV 16 ... undetectable HCV RNA after treatment for 24 or 48 weeks and maintaining a Sustained Virologic Response (SVR) 24 weeks after the last dose. (2) Patients with the following ...
2009 NOV 16 ... ribavirin. The results were presented in an abstract entitled "Sustained Virologic Response Results for Weight-Based Taribavirin Versus Weight-Based Ribavirin, in Na=EFve ...
